This Review highlights insights from recent clinical trials and discusses critical factors for optimizing cancer vaccines, with a focus on proxies for vaccine efficacy, neoantigen selection, modular platforms and early intervention.
- John B. Haanen
- Ton N. M. Schumacher
- Catherine J. Wu